Get startedLog in
    Picture of ISR Immune System Regulation Holding AB (publ) logo

    ISR — ISR Immune System Regulation Holding AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: ISR Signs Development Agreements With Catalent

    Picture of ISR Immune System Regulation Holding AB (publ) logoISR Immune System Regulation Holding AB (publ)
    28/06/2022 14:07
    June 28 (Reuters) - ISR Immune System Regulation Holding AB
(publ)  ISR.ST :
    * ISR SIGNS DEVELOPMENT AGREEMENTS WITH CATALENT TO SCALE-UP
ITS
SPRAY-DRIED NASAL VACCINE, POWDER FORMULATION FOR PHASE III.

Source text for Eikon:  ID:nWkr3BvFQ5 
Further company coverage:  ISR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on ISR Immune System Regulation Holding AB (publ)

    See all news